CWM
IDXX icon

Cedar Wealth Management’s Idexx Laboratories IDXX Stock Holding History

Cedar Wealth Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-7
Closed -$3.78K – 325
2024
Q1 		$3.78K Buy
+7
New +$3.83K ﹤0.01% 295

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Cedar Wealth Management's IDXX Position: Q2 2024 in Review

Cedar Wealth Management sold out of Idexx Laboratories (IDXX) in Q2 2024, closing a stake of 7 shares — an estimated $3.78K sold.

Cedar Wealth Management first reported a position in IDXX in Q1 2024 and held it in 1 quarter. The position peaked at $3.78K in Q1 2024. 1,110 funds tracked by Wall St. Rank hold IDXX as of Q2 2024.

  • Cedar Wealth Management reported no remaining Idexx Laboratories position as of Q2 2024 after selling out during the quarter.
  • Cedar Wealth Management sold 7 Idexx Laboratories shares in Q2 2024, an estimated $3.78K.
  • Cedar Wealth Management first reported a position in Idexx Laboratories in Q1 2024 and held it in 1 quarter.
  • Cedar Wealth Management's Idexx Laboratories position peaked at $3.78K in Q1 2024.
  • 1,110 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2024.

Based on Cedar Wealth Management's 13F filing for Q2 2024, filed 12 Aug 2024.